[SS-06] Neurology and ICD-11

[SS-06-3] Reserach framework for Alzheimer's disease

Philip Scheltens (Amsterdam University Medical Centers, The Netherlands)

One of the statutory duties of the WHO is to produce the International Classification of Diseases (ICD). The classification has a pivotal global influence on health statistics and policies. The new version; ICD-11 is long overdue since the previous one is a generation old. The ICD 11 is at its final step for implementation following a decade of preparation and discussions. The World Health Assembly shall make the final approval in May 2019.
In this new ICD, stroke for the first time is recognized as a neurological disorder since 1955. However, many challenges remain in some areas such as dementia. Prof Shakir the immediate past President of WFN and Chair of the ICD 11 Neurology TAG (Topic Advisory Group) and others will explain this complicated story. It would be of great value for neurologists to understand the structure of ICD-11 and the position of neurology among other fields of medicine. In addition, Japan has been a crucial contributor throughout the ICD-11 process, which will be explained by Dr. Mori form MHWL.

Prof. dr. Philip Scheltens studied at the VU University Amsterdam, gaining his MD in 1984, and PhD (Magnetic Resonance Imaging in Alzheimer's disease) in 1993. Since 2000 he is Professor of Cognitive Neurology and Director of the Alzheimer Center Amsterdam. His main interests are AD, FTD, MRI, PET imaging and fluid biomarkers. He is active in the field of biomarkers and clinical trials and has been the national PI for many studies, including phase 1-3 multicenter clinical trials. He founded and directs the Alzheimer Center since 2000, from which over 65 PhD theses have appeared since then. In 2013, he co-founded the Dutch national plan against dementia and serves as vice-chair of the board since then. He has authored over 920 peer reviewed publications (H-factor is 103). In 2011, he was elected as member of the Royal Dutch Academy of Arts and Sciences (KNAW) and serves as Secretary General since 2015. In 2016 he was awarded the European Grand Prix for Alzheimer’s Research